Paris staging system for primary gastrointestinal lymphomas [1]

Gut

Volumn 52, Issue 6, 2003, Pages 912-913

  Ruskone Fourmestroux A ^a   Drogosics, B ^b   Morgner, A ^c   Wotherspoon, A ^d   De Jong, D ^e  

^a HÔTEL DIEU   (France)

^b Gesundheitszentrum SÜd   (Austria)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INFILTRATION; CANCER STAGING; GASTROINTESTINAL TUMOR; HISTOPATHOLOGY; HUMAN; LETTER; LYMPH NODE METASTASIS; LYMPHOMA; PARIS STAGING SYSTEM; PRIORITY JOURNAL; STOMACH LYMPHOMA;

GASTROINTESTINAL NEOPLASMS; HUMANS; LYMPHOMA, NON-HODGKIN; NEOPLASM STAGING;

EID: 0037846397     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.6.912     Document Type: Letter

References (9)

1. Sackman M, Morgner A, Rudolph, B et al. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. Gastroenterology 1997;113:1087-90.
2. Steinbach G, Ford R, Glober G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. an uncontrolled trial. Ann Intern Med 1999;131:88-95.
3. Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, et al. Predictive factors for regression of gastric MALT lymphoma after anti- Helicobacter pylori treatment. Gut 2001;48:297-303.
4. Nakamura S, Matsumoto T, Suekane H, et al. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut 2001;48:454-60
5. Liu H, Ye H, Ruskone-Fourmestroux A, et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002;22:1286-94,
6. Krol AD, Herman J, Kramer MH, et al. Gastric lymphomas compared with lymph node lymphomas in a population-based registry differ in stage distribution and dissimination but not in patient survival. Cancer 1997;79:390-7.
7. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology 1992;102:1628-38.
8. Musshoff K. Klinische Stadieneinteilung der nicht-Hodgkin Lymphome (Clinical staging classification of non-Hodgkin's lymphomas (author's transl)). Strahlentherapie 1977;153:218-21.
9. Rohatiner A, D'Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994;5:397-400.